| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cancer Research Unit, Medical School, University of Newcastle upon Tyne, Newcastle upon Tyne [N. J. C.]; Imperial Cancer Research Fund Clinical Oncology Unit, Churchill Hospital, Headington, Oxon [A. L. H.]; Department of Biochemistry, University of Surrey, Guildford, Surrey [G. W. A.], England
The thymidylate synthase inhibitor N10-propargyl-5,8-dideazafolic acid (CB3717) inhibits the growth of human lung carcinoma A549 cells. The cytotoxicity of CB3717 is potentiated by the nucleoside transport inhibitor dipyridamole (DP), which not only inhibits the uptake and therefore salvage of thymidine but also inhibits the efflux of deoxyuridine, thereby enhancing the intracellular accumulation of deoxyuridine nucleotides. Measurement of intracellular deoxyuridine triphosphate (dUTP) pools, by sensitive radioimmunoassay, demonstrated a large increase in response to CB3717, in a dose- and time-related manner, and this accumulation was enhanced by coincubation with DP. In untreated cells and those treated with DP alone, dUTP was close to or below the limit of detection of the assay. In cells treated for 24 h with 3 µM CB3717 (concentration producing 50% growth inhibition) the intracellular dUTP was 46.1 ± 9.6 (SEM) pmol/106 cells and after 24 h exposure to 30 µM CB3717, 337.5 ± 37.9 pmol dUTP/106 cells was detected. There was significant enhancement by DP of the accumulation of dUTP in cells treated with CB3717; coincubation of cells with 1 µM DP + 3 µM CB3717 for 24 h resulted in intracellular dUTP levels of 174.7 ± 57.7 pmol/106 cells. Accumulation of DNA strand breaks, measured by alkaline elution, also increased in response to CB3717 concentration and exposure period. Newly synthesized (nascent) DNA was more sensitive to damage by CB3717 than was mature DNA. As with the accumulation of dUTP, coincubation with DP also enhanced the accumulation of strand breaks, whereas DP alone had little or no effect on DNA fragmentation.
When data for cells treated with CB3717 alone and CB3717 in combination with DP were combined, there was a significant correlation of intracellular dUTP levels with the level of DNA strand breaks. This strongly suggests that growth inhibition following thymidylate synthase inhibition is mediated through an increase in intracellular dUTP, leading to uracil misincorporation into DNA, its subsequent excision, and resultant strand breakage.
1 This work was supported by the North of England Cancer Research Campaign (N. J. C. and A. L. H.) and the Cancer Research Campaign of Great Britain (G. W. A.). A preliminary report of this work was presented at the Annual General Meeting of the British Association for Cancer Research, March 1990 (Br. J. Cancer, 62: 508, 1990).
Received 6/11/90. Accepted 2/13/91.
This article has been cited by other articles:
|
|
 |
|
  L. A. Parsels, J. D. Parsels, D. C.-H. Tai, D. J. Coughlin, and J. Maybaum 5-Fluoro-2'-Deoxyuridine-Induced cdc25A Accumulation Correlates with Premature Mitotic Entry and Clonogenic Death in Human Colon Cancer Cells Cancer Res., September 15, 2004; 64(18): 6588 - 6594. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. Koehler and R. D. Ladner Small Interfering RNA-Mediated Suppression of dUTPase Sensitizes Cancer Cell Lines to Thymidylate Synthase Inhibition Mol. Pharmacol., September 1, 2004; 66(3): 620 - 626. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Chen, D. J. Hunter, M. J. Stampfer, C. Kyte, W. Chan, J. G. Wetmur, R. Mosig, J. Selhub, and J. Ma Polymorphism in the Thymidylate Synthase Promoter Enhancer Region Modifies the Risk and Survival of Colorectal Cancer Cancer Epidemiol. Biomarkers Prev., October 1, 2003; 12(10): 958 - 962. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Wells, E. Aboagye, R. N. Gunn, S. Osman, A. V. Boddy, G. A. Taylor, I. Rafi, A. N. Hughes, A. H. Calvert, P. M. Price, et al. 2-[11C]Thymidine Positron Emission Tomography as an Indicator of Thymidylate Synthase Inhibition in Patients Treated With AG337 J Natl Cancer Inst, May 7, 2003; 95(9): 675 - 682. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. Tomicic, C. Friedrichs, M. Christmann, P. Wutzler, R. Thust, and B. Kaina Apoptosis Induced by (E)-5-(2-Bromovinyl)-2'-deoxyuridine in Varicella Zoster Virus Thymidine Kinase-Expressing Cells Is Driven by Activation of c-Jun/Activator Protein-1 and Fas Ligand/Caspase-8 Mol. Pharmacol., February 1, 2003; 63(2): 439 - 449. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. B. Longley, J. Boyer, W. L. Allen, T. Latif, P. R. Ferguson, P. J. Maxwell, U. McDermott, M. Lynch, D. P. Harkin, and P. G. Johnston The Role of Thymidylate Synthase Induction in Modulating p53-regulated Gene Expression in Response to 5-Fluorouracil and Antifolates Cancer Res., May 1, 2002; 62(9): 2644 - 2649. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. W. Aherne, A. Hardcastle, E. Ward, D. Dobinson, T. Crompton, M. Valenti, L. Brunton, and A. L. Jackman Pharmacokinetic/Pharmacodynamic Study of ZD9331, a Nonpolyglutamatable Inhibitor of Thymidylate Synthase, in a Murine Model Following Two Curative Administration Schedules Clin. Cancer Res., September 1, 2001; 7(9): 2923 - 2930. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. G. Smith, H. D. Thomas, H. C. Barlow, R. J. Griffin, B. T. Golding, A. H. Calvert, D. R. Newell, and N. J. Curtin In Vitro and in Vivo Properties of Novel Nucleoside Transport Inhibitors with Improved Pharmacological Properties That Potentiate Antifolate Activity Clin. Cancer Res., July 1, 2001; 7(7): 2105 - 2113. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Lau, M. L. Mole, M. F. Copeland, J. M. Rogers, R. J. Kavlock, D. L. Shuey, A. M. Cameron, D. H. Ellis, T. R. Logsdon, J. Merriman, et al. Toward a Biologically Based Dose-Response Model for Developmental Toxicity of 5-Fluorouracil in the Rat: Acquisition of Experimental Data Toxicol. Sci., January 1, 2001; 59(1): 37 - 48. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. D. Ladner, F. J. Lynch, S. Groshen, Y. P. Xiong, A. Sherrod, S. J. Caradonna, J. Stoehlmacher, and H.-J. Lenz dUTP Nucleotidohydrolase Isoform Expression in Normal and Neoplastic Tissues: Association with Survival and Response to 5-Fluorouracil in Colorectal Cancer Cancer Res., July 1, 2000; 60(13): 3493 - 3503. [Abstract] [Full Text]
|
|
|
|
|
|
S. J. Clarke, D. C. Farrugia, G. W. Aherne, D. M. Pritchard, J. Benstead, and A. L. Jackman Balb/c Mice as a Preclinical Model for Raltitrexed-induced Gastrointestinal Toxicity Clin. Cancer Res., January 1, 2000; 6(1): 285 - 296. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Oliveros, R. Garcia-Escudero, A. Alejo, E. Vinuela, M. L. Salas, and J. Salas African Swine Fever Virus dUTPase Is a Highly Specific Enzyme Required for Efficient Replication in Swine Macrophages J. Virol., November 1, 1999; 73(11): 8934 - 8943. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Wadler, S. Damle, H. Haynes, R. Kaleya, R. Schechner, R. Berkenblit, R. D. Ladner, and A. Murgo Phase II/Pharmacodynamic Trial of Dose-Intensive, Weekly Parenteral Hydroxyurea and Fluorouracil Administered With Interferon Alfa-2a in Patients With Refractory Malignancies of the Gastrointestinal Tract J. Clin. Oncol., June 1, 1999; 17(6): 1771 - 1771. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Parsels, R. C. Zellars, T. L. Loney, J. D. Parsels, M. F. Clarke, A. K. Merchant, T. S. Lawrence, and J. Maybaum Prevention of Fluorodeoxyuridine-Induced Cytotoxicity and DNA Damage in HT29 Colon Carcinoma Cells by Conditional Expression of Wild-Type p53 Phenotype Mol. Pharmacol., October 1, 1997; 52(4): 600 - 605. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. D. Ladner and S. J. Caradonna The Human dUTPase Gene Encodes both Nuclear and Mitochondrial Isoforms. DIFFERENTIAL EXPRESSION OF THE ISOFORMS AND CHARACTERIZATION OF A cDNA ENCODING THE MITOCHONDRIAL SPECIES J. Biol. Chem., July 25, 1997; 272(30): 19072 - 19080. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. J. Oliver, M. K.L. Collins, and A. Lopez-Rivas Overexpression of a Heterologous Thymidine Kinase Delays Apoptosis Induced by Factor Deprivation and Inhibitors of Deoxynucleotide Metabolism J. Biol. Chem., April 18, 1997; 272(16): 10624 - 10630. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-B. Yin, W. Voigt, A. Panadero, U. Vanhoefer, C. Frank, S. Pajovic, J. Azizkhan, and Y. M. Rustum p53 and WAF1 Are Induced and Rb Protein Is Hypophosphorylated during Cell Growth Inhibition by the Thymidylate Synthase Inhibitor ZD1694 (Tomudex) Mol. Pharmacol., April 1, 1997; 51(4): 630 - 636. [Abstract] [Full Text]
|
|
|
|
 |
|
 D. M. Pritchard, A. J. M. Watson, C. S. Potten, A. L. Jackman, and J. A. Hickman Inhibition by uridine but not thymidine of p53-dependent intestinal apoptosis initiated by 5-fluorouracil: Evidence for the involvement of RNA perturbation PNAS, March 4, 1997; 94(5): 1795 - 1799. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. A. Roseman, R. K. Evans, E. L. Mayer, M. A. Rossi, and M. B. Slabaugh Purification and Characterization of the Vaccinia Virus Deoxyuridine Triphosphatase Expressed in Escherichia coli J. Biol. Chem., September 20, 1996; 271(38): 23506 - 23511. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. D. Ladner, D. E. McNulty, S. A. Carr, G. D. Roberts, and S. J. Caradonna Characterization of Distinct Nuclear and Mitochondrial Forms of Human Deoxyuridine Triphosphate Nucleotidohydrolase J. Biol. Chem., March 29, 1996; 271(13): 7745 - 7751. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
